Receives Patent for Use of Topical Clotrimazole For Treatment of Actinic Keratosis NEW YORK, Sept. 19 /PRNewswire/ -- Ion Pharmaceuticals, Inc., a wholly owned subsidiary of Sheffield Medical Technologies, Inc. (AMEX: SHM) announced today that it has initiated a Phase I/II human clinical trial of ...